Literature DB >> 20889503

Homocysteine, another risk factor for Alzheimer disease, impairs apolipoprotein E3 function.

Hirohisa Minagawa1, Atsushi Watanabe, Hiroyasu Akatsu, Kayo Adachi, Chigumi Ohtsuka, Yasuo Terayama, Takashi Hosono, Satoshi Takahashi, Hideaki Wakita, Cha-Gyun Jung, Hiroto Komano, Makoto Michikawa.   

Abstract

Apolipoprotein E (apoE) ε4 and hyperhomocysteinemia are risk factors for Alzheimer disease (AD). The dimerization of apoE3 by disulfide bonds between cysteine residues enhances apoE3 function to generate HDL. Because homocysteine (Hcy) harbors a thiol group, we examined whether Hcy interferes with the dimerization of apoE3 and thereby impairs apoE3 function. We found that Hcy inhibits the dimerization of apoE3 and reduces apoE3-mediated HDL generation to a level similar to that by apoE4, whereas Hcy does not affect apoE4 function. Western blot analysis of cerebrospinal fluid showed that the ratio of apoE3 dimers was significantly lower in the samples from the patients with hyperhomocysteinemia than in those that from control subjects. Hyperhomocysteinemia induced by subcutaneous injection of Hcy to apoE3 knock-in mice decreased the level of the apoE3 dimer in the brain homogenate. Because apoE-HDL plays a role in amyloid β-protein clearance, these results suggest that two different risk factors, apoE4 and hyperhomocysteinemia, may share a common mechanism that accelerates the pathogenesis of AD in terms of reduced HDL generation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20889503      PMCID: PMC2992271          DOI: 10.1074/jbc.M110.146258

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice.

Authors:  H Hamanaka; Y Katoh-Fukui; K Suzuki; M Kobayashi; R Suzuki; Y Motegi; Y Nakahara; A Takeshita; M Kawai; K Ishiguro; M Yokoyama; S C Fujita
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

2.  Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer.

Authors:  Qin Xu; Walter J Brecht; Karl H Weisgraber; Robert W Mahley; Yadong Huang
Journal:  J Biol Chem       Date:  2004-03-30       Impact factor: 5.157

3.  Homocysteine and folate as risk factors for dementia and Alzheimer disease.

Authors:  Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Mabel Martelli; Lucia Servadei; Nicoletta Brunetti; Elisa Porcellini; Federico Licastro
Journal:  Am J Clin Nutr       Date:  2005-09       Impact factor: 7.045

4.  Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.

Authors:  Chiaki Isobe; Takahiko Murata; Chigumi Sato; Yasuo Terayama
Journal:  Life Sci       Date:  2005-08-26       Impact factor: 5.037

5.  A novel action of alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release.

Authors:  M Michikawa; J S Gong; Q W Fan; N Sawamura; K Yanagisawa
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

6.  Homocysteine induces cell death of rat astrocytes in vitro.

Authors:  J M Maler; W Seifert; G Hüther; J Wiltfang; E Rüther; J Kornhuber; S Bleich
Journal:  Neurosci Lett       Date:  2003-08-21       Impact factor: 3.046

7.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.

Authors:  G Starkebaum; J M Harlan
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

8.  Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.

Authors:  Javier Pacheco-Quinto; Elena B Rodriguez de Turco; Steven DeRosa; Altovise Howard; Felix Cruz-Sanchez; Kumar Sambamurti; Lorenzo Refolo; Suzana Petanceska; Miguel A Pappolla
Journal:  Neurobiol Dis       Date:  2006-03-03       Impact factor: 5.996

9.  Plasma homocysteine levels and risk of Alzheimer disease.

Authors:  J A Luchsinger; M-X Tang; S Shea; J Miller; R Green; R Mayeux
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

10.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more
  13 in total

1.  High levels of homocysteine downregulate apolipoprotein E expression via nuclear factor kappa B.

Authors:  Violeta G Trusca; Adina D Mihai; Elena V Fuior; Ioana M Fenyo; Anca V Gafencu
Journal:  World J Biol Chem       Date:  2016-02-26

2.  Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.

Authors:  Kazuchika Nishitsuji; Takashi Hosono; Toshiyuki Nakamura; Guojun Bu; Makoto Michikawa
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

Review 3.  Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer's disease.

Authors:  Federico Cacciapuoti
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

4.  Low-Dose Homocystine Enhances Proliferation and Migration of Bv2 Microglia Cells.

Authors:  Lishu Wan; Yingjie Sun; Fan Zhang; Yan Ren
Journal:  Cell Mol Neurobiol       Date:  2016-01-29       Impact factor: 5.046

5.  KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Patients.

Authors:  Michael Malek-Ahmadi; Amar Patel; Marwan N Sabbagh
Journal:  Int J Alzheimers Dis       Date:  2013-12-24

6.  Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients?

Authors:  Federica Boraldi; Sonia Costa; Claudio Rabacchi; Miriam Ciani; Olivier Vanakker; Daniela Quaglino
Journal:  Mol Genet Metab Rep       Date:  2014-11-16

7.  Deciphering the Link Between Hyperhomocysteinemia and Ceramide Metabolism in Alzheimer-Type Neurodegeneration.

Authors:  Hervé Le Stunff; Julien Véret; Nadim Kassis; Jessica Denom; Kelly Meneyrol; Jean-Louis Paul; Céline Cruciani-Guglielmacci; Christophe Magnan; Nathalie Janel
Journal:  Front Neurol       Date:  2019-07-31       Impact factor: 4.003

8.  Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.

Authors:  Zhijie Xiao; Juan Wang; Weirong Chen; Peng Wang; Houlin Zeng; Weixi Chen
Journal:  Lipids Health Dis       Date:  2012-11-26       Impact factor: 3.876

9.  Mild Hyperhomocysteinemia Causes Anxiety-like Behavior and Brain Hyperactivity in Rodents: Are ATPase and Excitotoxicity by NMDA Receptor Overstimulation Involved in this Effect?

Authors:  Tiago Marcon Dos Santos; Cassiana Siebert; Larissa Daniele Bobermin; André Quincozes-Santos; Angela T S Wyse
Journal:  Cell Mol Neurobiol       Date:  2021-07-29       Impact factor: 4.231

Review 10.  DNA methylation, a hand behind neurodegenerative diseases.

Authors:  Haoyang Lu; Xinzhou Liu; Yulin Deng; Hong Qing
Journal:  Front Aging Neurosci       Date:  2013-12-05       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.